Rare Diseases, Urpis: "Make a Lot More Flexible and Faster Path to Marking"
4 Articles
4 Articles
To date there are many difficulties in achieving the marking and therefore being able to put on the market medical devices intended for indications or rare diseases, Urpis explains, because the regulation EU 2017/735 that regulates the sector has brought much more rigour and stringent rules. Marina Urpis, medical and health manager at the Office VI of the [...] L'articolo Rare Diseases, Urpis: "Make much more flexible and faster path towards mar…
(Adnkronos) - "To date there are many difficulties in achieving marking and therefore being able to put on the market medical devices intended for indications or rare diseases," explains Urpis, because the EU regulation 2017/735 that...
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium






